IN Brief:
- ALDI US will remove 44 additional ingredients from private-label food, vitamin, and supplement products by the end of 2027.
- The retailer’s restricted list will rise from 13 to 57 items, covering a wider range of colours, sweeteners, preservatives, and additives.
- Retailer-led ingredient standards are pushing more reformulation, relabelling, and specification work into manufacturing supply chains.
ALDI US will eliminate 44 additional ingredients from its private-label food, vitamin, and supplement products by the end of 2027, increasing its restricted ingredient list from 13 items to 57. The new exclusions cover a wider spread of colours, preservatives, sweeteners, and other additives used either directly in finished products or through compound ingredients supplied into them.
Among the ingredients added to the list are bromated flour, titanium dioxide, neotame, and acesulfame potassium, alongside a broader set of materials the retailer no longer wants used across its private-label ranges. Reformulated products will begin to appear in phases through 2027, with updated labelling introduced as revised products move through the pipeline.
The change will be felt well beyond finished-goods specification sheets. Private-label manufacturing depends on complex supply relationships that often include premixes, bakery improvers, seasoning systems, stabiliser blends, flavour compounds, and other supplied ingredient systems. Once a broader exclusion list is introduced, compliance work has to move across procurement, product development, quality, regulatory, packaging, and supplier management rather than staying within one R&D function.
Reformulation of this kind can also affect manufacturing performance. Removing a preservative, dough improver, colour, or sweetener can alter shelf life, texture, machinability, flavour balance, moisture control, or thermal stability. In bakery, beverages, confectionery, ambient grocery, and supplement products, relatively small ingredient changes can reshape process behaviour on the line and product stability after packing. Manufacturers often need repeated trials, revised specifications, and additional validation work before a substitute is ready for routine production.
Retailer ingredient policies have become a stronger force in the US private-label market, where customer standards are often moving faster than formal regulatory change. That places suppliers under growing pressure to meet overlapping customer requirements while managing cost, performance, and stock complexity. A restricted list from a major retailer can affect raw-material choices and development priorities across multiple sites, especially where suppliers serve several private-label customers with different standards.
ALDI’s decision also reflects a broader commercial shift in food manufacturing, where product acceptance is increasingly shaped by how ingredients are perceived as well as how they perform. That has already driven changes in colours, sweeteners, preservatives, and flour treatment agents across a range of products. The challenge for manufacturers is to make those changes without compromising product stability, line efficiency, or unit economics.
For suppliers, the workload begins well ahead of the retailer deadline. Reformulation programmes require ingredient sourcing, sensory checks, shelf-life testing, artwork updates, inventory management, and in many cases fresh sign-off from customers. The more widely a product family is distributed, the more coordination is required. When the restricted list expands at scale, the knock-on effect spreads quickly through development pipelines and production schedules.
ALDI’s latest move adds another layer to that process. The deadline runs to the end of 2027, but the technical and operational work is already on the table.
